Corbus Pharmaceuticals Holdings, Inc. Tax Credit Carryforward, Amount
Corbus Pharmaceuticals Holdings, Inc. (CRBP) had Tax Credit Carryforward, Amount of $1.76 million as of 2020-12-31, per its 10-Q filed 2021-08-12.
Discontinued › Notes › Income Taxes
us-gaap:TaxCreditCarryforwardAmount · last filed 2021-08-12
- 2020-12-31: Tax Credit Carryforward, Amount $1.76M.
| Period end | Tax Credit Carryforward, Amount |
|---|---|
| 2020-12-31 | $1.76M 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |